Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Nerivio Remote Electrical Neuromodulation Device for Migraine
Manufacturer/Marketed By : DR REDDY'S LABORATORIES LTD
$159.73 $127.78
Nerivio Remote Electrical Neuromodulation (REN) Device is a non-invasive, FDA-approved therapy designed for the acute treatment of migraine in individuals aged 12 years and older. This device uses remote electrical...
Active Pharmaceutical Ingredient
Nerivio Remote Electrical Neuromodulation Device for Migraine
$159.73
$127.78
Nerivio Remote Electrical Neuromodulation (REN) Device is a non-invasive, FDA-approved therapy designed for the acute treatment of migraine in individuals aged 12 years and older. This device uses remote electrical stimulation applied to the upper arm to modulate pain signals and relieve migraine attacks effectively. It is a user-friendly, wireless device controlled through a smartphone app, making it convenient for at-home use. The active mechanism involves neuromodulation through electrical pulses that stimulate the body's Conditioned Pain Modulation (CPM) system. Nerivio provides pain relief by triggering the release of serotonin and norepinephrine, two neurotransmitters that play a key role in reducing headache severity. While generally safe, Nerivio should not be used by individuals with implanted medical devices, severe heart conditions, or epilepsy. Pregnant or breastfeeding women should consult their doctor before using this device.
Active Pharmaceutical Ingredient
Uses
• Acute treatment of migraine with or without aura in patients aged 12 years and above.
• Can be used for episodic and chronic migraine management.
Benefits
Nerivio works by delivering electrical pulses to the C-fiber nerves in the upper arm, which transmit signals to the brainstem. This process activates the brain’s Conditioned Pain Modulation (CPM) mechanism, leading to the release of pain-inhibiting chemicals such as serotonin and norepinephrine. These neurotransmitters reduce pain perception and alleviate migraine symptoms effectively.
Side Effects
Common side effects:
Most Common Side Effects
• Severe skin irritation or allergic reaction.
• Electrical sensitivity or increased discomfort during use.
Common Side Effects
• Mild skin irritation or redness at the application site.
• Tingling or numbness in the arm during or after use.
How To Use
To use the Nerivio device effectively, place it on the upper arm of the non-dominant side (opposite hand to the one you write with) and secure it properly. Activate the device using the companion smartphone app, which allows you to control the intensity and duration of the session. For acute migraine attacks, use the device within 60 minutes of headache onset, with a standard session lasting 45 minutes. For preventive treatment, use the device for 45 minutes every alternate day. Always follow the instructions provided in the user manual and consult your doctor before adjusting the duration or frequency of sessions.
Safety Advice
• Breast Feeding: The effects of Nerivio on breastfeeding mothers and infants are unknown. It is advisable to inform your doctor before starting the treatment.
• Alcohol: The interaction of Nerivio with alcohol consumption is not well studied. Avoid excessive alcohol consumption while using this device.
• Liver: There is no conclusive data on the safety of using Nerivio in patients with chronic liver disease. It is best to consult your doctor before using the device.
• Lungs: No established data is available on the use of Nerivio in individuals with chronic lung diseases. Inform your doctor if you have any respiratory issues before use.
• Driving: Nerivio does not impair driving abilities. However, avoid using the device while driving or operating heavy machinery.
• Pregnancy: There is limited data on the safety of Nerivio during pregnancy. It is recommended to consult a healthcare provider before using the device if you are pregnant.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.